BioMark Oncology Company Profile, Contacts & Intelligence

BioMark Oncology Overview

BioMark Oncology is a translationally enabled cancer therapeutics company. We are developing potential first-in-class medicines for solid tumor indications with mechanisms of action and target validation focused on whole systems biology. We believe that this approach, akin to the discovery of immune checkpoint inhibition targets, will enable the next step-function change in solid tumor efficacy and move previously overlooked but valuable targets forward. To derisk these programs, we are developing a multi-omics predictive biomarker platform measuring >1000 plasma biomarkers. We use machine learning cluster analysis to find systemic differences in responders and nonresponders in a heterogeneous patient population. This will enable host-based predictive biomarkers to complement tumor-based strategies to select the right cancer drug for the right patient.

Headquarters

Thousand Oaks, California, United States

Industry

Biotechnology Research

Founded

2021

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

BioMark Oncology Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

BioMark Oncology People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

BioMark Oncology Workforce Composition

Seniority breakdown across 3 visible profiles.

Compare Similar Companies to BioMark Oncology

Explore companies in related markets and compare their industry and employee estimates.